Oruka Therapeutics, Inc. Quarterly Entity Common Stock, Shares Outstanding from Q2 2011 to Q3 2024

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
Oruka Therapeutics, Inc. quarterly Entity Common Stock, Shares Outstanding history and growth rate from Q2 2011 to Q3 2024.
  • Oruka Therapeutics, Inc. Entity Common Stock, Shares Outstanding for the quarter ending October 31, 2024 was 35M shares, a 143% increase year-over-year.
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 35M +20.6M +143% Oct 31, 2024 10-Q 2024-11-13
Q2 2024 14.5M +97K +0.67% Jul 31, 2024 10-Q 2024-08-01
Q1 2024 14.5M +97K +0.67% Apr 24, 2024 10-Q 2024-04-25
Q4 2023 14.5M Jan 31, 2024 10-K 2024-02-01
Q3 2023 14.4M 0 0% Oct 17, 2023 10-Q 2023-10-18
Q2 2023 14.4M 0 0% Jul 20, 2023 10-Q 2023-07-21
Q1 2023 14.4M 0 0% Apr 24, 2023 10-Q 2023-04-24
Q3 2022 14.4M 0 0% Oct 27, 2022 10-Q 2022-10-28
Q2 2022 14.4M 0 0% Aug 1, 2022 10-Q 2022-08-02
Q1 2022 14.4M 0 0% Mar 11, 2022 10-K 2022-03-14
Q3 2021 14.4M +5.09M +54.6% Nov 1, 2021 10-Q 2021-11-02
Q2 2021 14.4M +8.5M +144% Aug 3, 2021 10-Q 2021-08-04
Q1 2021 14.4M +12.8M +804% Mar 16, 2021 10-K 2021-03-18
Q3 2020 9.32M +7.73M +485% Oct 30, 2020 10-Q 2020-11-02
Q2 2020 5.91M +4.45M +306% Jul 31, 2020 10-Q 2020-08-05
Q1 2020 1.59M +495K +45.1% May 5, 2020 10-Q 2020-05-06
Q4 2019 1.59M Feb 13, 2020 10-K 2020-02-18
Q3 2019 1.59M -12.3M -88.6% Nov 1, 2019 10-Q 2019-11-06
Q2 2019 1.46M -12.5M -89.5% Jul 31, 2019 10-Q 2019-08-01
Q1 2019 1.1M -12.8M -92.1% May 6, 2019 10-Q 2019-05-08
Q3 2018 13.9M +2.17M +18.5% Nov 12, 2018 10-Q 2018-11-14
Q2 2018 13.9M +2.17M +18.5% Aug 7, 2018 10-Q 2018-08-09
Q1 2018 13.9M +4.78M +52.4% Mar 19, 2018 10-K 2018-03-22
Q3 2017 11.8M +2.67M +29.4% Nov 7, 2017 10-Q 2017-11-09
Q2 2017 11.8M +2.68M +29.6% Jul 31, 2017 10-Q 2017-08-03
Q1 2017 9.13M +74.3K +0.82% Mar 17, 2017 10-K 2017-03-21
Q3 2016 9.08M +31.1K +0.34% Nov 10, 2016 10-Q 2016-11-14
Q2 2016 9.07M -54.2M -85.7% Aug 5, 2016 10-Q 2016-08-09
Q1 2016 9.06M -12.1M -57.3% Mar 15, 2016 10-K 2016-03-17
Q3 2015 9.05M -12.1M -57.2% Nov 10, 2015 10-Q 2015-11-12
Q2 2015 63.2M +42.2M +201% Aug 7, 2015 10-Q 2015-08-11
Q1 2015 21.2M +219K +1.04% Mar 17, 2015 10-K 2015-03-19
Q3 2014 21.2M +5.47M +34.9% Nov 10, 2014 10-Q 2014-11-12
Q2 2014 21M +10.1M +91.9% Aug 12, 2014 10-Q 2014-08-13
Q1 2014 21M +17.8M +559% Mar 17, 2014 10-K 2014-03-20
Q3 2013 15.7M +231K +1.49% Nov 8, 2013 10-Q 2013-11-13
Q2 2013 11M -3.67M -25.1% Aug 9, 2013 10-Q 2013-08-13
Q1 2013 3.19M -9M -73.9% Mar 18, 2013 10-K 2013-03-21
Q3 2012 15.4M +4.93M +46.9% Nov 9, 2012 10-Q 2012-11-13
Q2 2012 14.6M +4.1M +39% Aug 10, 2012 10-Q 2012-08-13
Q1 2012 12.2M Mar 23, 2012 10-K 2012-03-27
Q3 2011 10.5M Nov 9, 2011 10-Q 2011-11-14
Q2 2011 10.5M Aug 11, 2011 10-Q 2011-08-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.